Ciglitazone

1-(tetrahydro-pyran-2-yl)-6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indazole.

2-[cis-2,6-dimethyl-3,6-dihydro-2H-pyran-4-yl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane.

2-[cis-2,6-dimethyl-3,6-dihydro-2H-pyran-4-yl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane.

2-[cis-2,6-dimethyl-3,6-dihydro-2H-pyran-4-yl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane.

2-Methyl-5，6，7，8-tetrahydro-[1，2，4]triazolo[1，5-a]pyrazine.

U-46619 is a TP receptor agonist that exhibits properties similar to TXA2, inducing platelet aggregation and vascular smooth muscle contraction. 5-trans U-46619 is a minor impurity (2-5%) which is variably present in most commercial preparations of

U-46619 is a TP receptor agonist that exhibits properties similar to TXA2, inducing platelet aggregation and vascular smooth muscle contraction. 5-trans U-46619 is a minor impurity (2-5%) which is variably present in most commercial preparations of

U-46619 is a TP receptor agonist that exhibits properties similar to TXA2, inducing platelet aggregation and vascular smooth muscle contraction. 5-trans U-46619 is a minor impurity (2-5%) which is variably present in most commercial preparations of

Anti-BCAR3 breast cancer anti-estrogen resistance 3, 25ul UN

Immunogen Synthetic peptide directed towards the N terminal region of human CAMKK2 Biochem/physiol Actions CAMKK2 is a calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number

Immunogen Cell division cycle and apoptosis regulator protein 1 recombinant protein epitope signature tag (PrEST) Application Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.

General description The ACK2 antibody is specific for CD117, also called c-Kit, a 145 kDa cytokine receptor important in the development of hematopoietic stem cells, in oogenesis, and for functional activity of immune cells such as NK and mast